SAN FRANCISCO: SmartRecruiters, which specialises in artificial-intelligence driven recruiting methods, has released Winston, an AI-powered recruiting companion that it claims will change the way recruitment technology operates.
Chief Executive, Rebecca Carr said Winston did not just reduce administrative tasks in recruiting — it eliminated them.
“From screening candidates and scheduling interviews to sending follow-up notes, Winston frees hiring teams to focus on the most human part of the process — the interview,” Ms Carr (pictured) said.
She said traditional methods were not meeting the expectations of hiring managers and recruiters, especially in high-volume, high-turnover industries, such as retail and manufacturing.
“We needed something more adaptive, more human, and that’s Winston. He’s not just a feature; he's the future of recruitment technology, designed to remove the manual, administrative burden from hiring teams, giving them back the time to focus on the heart of hiring: Connecting with great talent,” Ms Carr said.
*********
Ardena strengthens US connection
GHENT: Belgium-based Pharmaceutical Contract Development and Manufacturing company, Ardena has signed an agreement to acquire Catalent’s facility in Somerset, New Jersey.
The Somerset facility employs approximately 200 scientists and technicians and is a Centre of Excellence for advanced delivery of oral dosage forms, significantly enhancing Ardena’s capabilities in downstream late-stage and small-scale commercial manufacturing of oral drug products.
Chief Executive of Ardena, Jeremie Trochu said the acquisition positioned Ardena to expand its bioanalytical services in the United States, serving a growing client base driven by an ever-increasing demand for advanced drug development services.
“The Somerset facility's specialised technologies and analytical capabilities bolster Ardena’s integrated offering, providing comprehensive solutions for pharmaceutical and biotechnology customers on both sides of the Atlantic,” Mr Trochu said.
*********
Cogstate appoints Alzheimer drug expert
MELBOURNE: Neuroscience technology company, Cogstate has appointed Kaycee Sink as its Chief Medical Officer. In this role, Dr Sink will lead Cogstate’s support of clinical trials in Alzheimer’s disease and other neurodegenerative disorders.
Chief Executive, Brad O’Connor said Dr Sink would use her extensive experience in Alzheimer’s disease drug development to advise biopharmaceutical leaders through strategic trial design decisions, endpoint selection, and data quality considerations.
“She will also play a critical role in Cogstate’s efforts to commercialise cognitive assessment technologies within the community to support timely and more accurate diagnoses in healthcare,” Mr O’Connor said.
“The medical, research, and pharmaceutical development expertise she brings will strengthen the value we offer our customers who seek to accelerate the development of new Alzheimer’s disease therapeutics, making brain health awareness and action a normal part of aging.”
*********
Hinen to exhibit renewables expertise
MELBOURNE: electronics company, Hinen Group has announced it will be part of the All Energy Australia 2024 exhibition at the Melbourne Convention and Exhibition Centre on October 23 and 24.
Australia's largest and only dedicated renewable energy exhibition will bring together experts and representatives from the energy industry to discuss the future of renewable energy.
In a statement, the company said its products aimed to support Australia's energy transition.
“We look forward to connecting with industry professionals, witnessing cutting-edge technology, and exploring a smarter, more efficient and sustainable energy future together," the statement said.
*********
Liberia rail move boost for HPX
MONROVIA: Liberian President, Joseph N. Boakai has released an Executive Order establishing a National Railway Authority, setting the stage for the development of infrastructure owned by the Government, but independently managed.
The move has been welcomed by HPX, an American exploration and development company which operates projects in the country.
President and Chief Executive of HPX, Bronwyn Barnes was among senior management that visited Monrovia to finalise a rail access agreement for the existing Yekepa-to-Buchanan line.
“Key provisions in this agreement facilitate the advancement of HPX’s Liberty Corridor project, enabling it to proceed to the detailed feasibility study phase,” Ms Barnes said.
An occasional round-up of international business stories
No comments:
Post a Comment